2seventy bio, Inc.
TSVT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $22,938 | $2,926 | $13,534 | $8,967 |
| % Growth | 683.9% | -78.4% | 50.9% | – |
| Cost of Goods Sold | $5,153 | $8,843 | $5,768 | $1,346 |
| Gross Profit | $17,785 | -$5,917 | $7,766 | $7,621 |
| % Margin | 77.5% | -202.2% | 57.4% | 85% |
| R&D Expenses | $5,399 | $8,653 | $8,320 | $16,013 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $14,849 | $8,524 | $12,884 | $9,857 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $57 | $172 | $503 | $11,320 |
| Operating Expenses | $20,305 | $17,349 | $21,707 | $37,190 |
| Operating Income | -$2,520 | -$23,266 | -$13,941 | -$20,356 |
| % Margin | -11% | -795.1% | -103% | -227% |
| Other Income/Exp. Net | $3,002 | $3,746 | $4,008 | $51,948 |
| Pre-Tax Income | $482 | -$19,520 | -$9,933 | $24,879 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $482 | -$19,520 | -$9,933 | $24,879 |
| % Margin | 2.1% | -667.1% | -73.4% | 277.5% |
| EPS | 0.009 | -0.37 | -0.19 | 0.48 |
| % Growth | 102.5% | -94.7% | -139.6% | – |
| EPS Diluted | 0.009 | -0.37 | -0.19 | 0.45 |
| Weighted Avg Shares Out | 53,055 | 52,334 | 52,263 | 52,186 |
| Weighted Avg Shares Out Dil | 53,433 | 52,334 | 52,263 | 55,011 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,321 | $2,632 | $2,855 | $2,527 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,638 | $1,655 | $1,658 | $1,676 |
| EBITDA | -$825 | -$21,439 | -$11,780 | -$18,680 |
| % Margin | -3.6% | -732.7% | -87% | -208.3% |